Cargando…

Bone Mineral Density and Current Bone Health Screening Practices in Friedreich’s Ataxia

INTRODUCTION: Friedreich’s Ataxia (FRDA) is a progressive neurological disorder caused by mutations in both alleles of the frataxin (FXN) gene. Impaired bone health is a complication of other disorders affecting mobility, but there is little information regarding bone health in FRDA. METHODS: Dual e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunn, Julia, Tamaroff, Jaclyn, DeDio, Anna, Nguyen, Sara, Wade, Kristin, Cilenti, Nicolette, Weber, David R., Lynch, David R., McCormack, Shana E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964400/ https://www.ncbi.nlm.nih.gov/pubmed/35368287 http://dx.doi.org/10.3389/fnins.2022.818750

Ejemplares similares

In vivo assessment of OXPHOS capacity using 3 T CrCEST MRI in Friedreich’s ataxia
por: Schur, Gayatri Maria, et al.
Publicado: (2021)

Friedreich Ataxia: Multidisciplinary Clinical Care
por: Lynch, David R, et al.
Publicado: (2021)

MON-LB030 Muscle Mitochondrial Oxidative Phosphorylation Capacity and Whole Body Glucose Metabolism in Friedreich's Ataxia
por: Nguyen, Sara, et al.
Publicado: (2019)

Body Mass Index and Height in the Friedreich Ataxia Clinical Outcome Measures Study
por: Patel, Maya, et al.
Publicado: (2021)

Impact of diabetes in the Friedreich ataxia clinical outcome measures study
por: McCormick, Ashley, et al.
Publicado: (2017)

Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle
por: Vásquez-Trincado, César, et al.
Publicado: (2022)

Predictors of loss of ambulation in Friedreich's ataxia
por: Rummey, Christian, et al.
Publicado: (2020)

Randomized, double‐blind, placebo‐controlled study of interferon‐γ 1b in Friedreich Ataxia
por: Lynch, David R., et al.
Publicado: (2019)

Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice
por: Kemp, Kevin C., et al.
Publicado: (2018)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

Central Nervous System Therapeutic Targets in Friedreich Ataxia
por: Harding, Ian H., et al.
Publicado: (2020)

Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia
por: Rodden, Layne N., et al.
Publicado: (2022)

Consensus clinical management guidelines for Friedreich ataxia
por: Corben, Louise A, et al.
Publicado: (2014)

Longitudinal analysis of contrast acuity in Friedreich ataxia
por: Hamedani, Ali G., et al.
Publicado: (2018)

Somatic instability of the expanded GAA repeats in Friedreich’s ataxia
por: Long, Ashlee, et al.
Publicado: (2017)

Test–retest reliability of the Friedreich’s ataxia rating scale
por: Rummey, Christian, et al.
Publicado: (2020)

SARS-CoV-2 in patients with Friedreich ataxia
por: Shen, Megan M., et al.
Publicado: (2022)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Selected missense mutations impair frataxin processing in Friedreich ataxia
por: Clark, Elisia, et al.
Publicado: (2017)

Friedreich Ataxia and nephrotic syndrome: a series of two patients
por: Shinnick, Julianna E., et al.
Publicado: (2016)

Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation
por: Rodden, Layne N., et al.
Publicado: (2021)

Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions
por: Lynch, David R., et al.
Publicado: (2021)

Psychometric properties of the Friedreich Ataxia Rating Scale
por: Rummey, Christian, et al.
Publicado: (2019)

Frataxin levels in peripheral tissue in Friedreich ataxia
por: Lazaropoulos, Michael, et al.
Publicado: (2015)

FXN gene methylation determines carrier status in Friedreich ataxia
por: Lam, Christina, et al.
Publicado: (2023)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015)

Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia
por: Mercado-Ayón, Elizabeth, et al.
Publicado: (2022)

Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)

Depressive symptoms in Friedreich ataxia
por: Nieto, Antonieta, et al.
Publicado: (2018)

Heart disease in Friedreich’s ataxia
por: Hanson, Emily, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Two Cases of Friedreich’s Ataxia
por: Stephenson, F. H.
Publicado: (1897)

Respiratory Function in Friedreich’s Ataxia
por: Vinante, Elena, et al.
Publicado: (2022)

Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia
por: Rodden, Layne N., et al.
Publicado: (2023)

Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)
por: Lynch, David R., et al.
Publicado: (2020)

Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia
por: Lynch, David R., et al.
Publicado: (2018)

Deep sequencing of mitochondrial genomes reveals increased mutation load in Friedreich's ataxia
por: Bhalla, Angela D., et al.
Publicado: (2016)

ODP576 A pilot randomized clinical trial of intranasal oxytocin to promote weight loss in children, adolescents, and adults with hypothalamic obesity
por: Bamba, Vaneeta, et al.
Publicado: (2022)

Development of Frataxin Gene Expression Measures for the Evaluation of Experimental Treatments in Friedreich’s Ataxia
por: Plasterer, Heather L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bt9g26l3isc9se0hgc1f516g1h